mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |